WHO GRADE 4 GLIOMA

Clinical trials for WHO GRADE 4 GLIOMA explained in plain language.

Never miss a new study

Get alerted when new WHO GRADE 4 GLIOMA trials appear

Sign up with your email to follow new studies for WHO GRADE 4 GLIOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 3 Not yet recruiting 2 Not yet finished but already full! 1

New drug combo shows promise for kids with aggressive brain tumors

Disease control Ongoing

This phase 2 trial tests whether two targeted drugs, dabrafenib and trametinib, can improve outcomes for children and young adults with a specific type of high-grade glioma (BRAF V600-mutant) after they receive radiation therapy. The study enrolls 58 participants aged 25 or young…

Matched conditions: WHO GRADE 4 GLIOMA

Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated Jun 27, 2026 12:37 UTC

WHO GRADE 4 GLIOMA

Get alerted when new WHO GRADE 4 GLIOMA trials appear

New drug combo shows promise for kids with aggressive brain tumors